SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-015781
Filing Date
2022-11-01
Accepted
2022-11-01 16:02:04
Documents
86
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q icpt-20220930x10q.htm   iXBRL 10-Q 2498844
2 EX-31.1 icpt-20220930xex31d1.htm EX-31.1 9881
3 EX-31.2 icpt-20220930xex31d2.htm EX-31.2 9864
4 EX-32.1 icpt-20220930xex32d1.htm EX-32.1 10351
  Complete submission text file 0001558370-22-015781.txt   11209388

Data Files

Seq Description Document Type Size
5 EX-101.SCH icpt-20220930.xsd EX-101.SCH 64642
6 EX-101.CAL icpt-20220930_cal.xml EX-101.CAL 90575
7 EX-101.DEF icpt-20220930_def.xml EX-101.DEF 301888
8 EX-101.LAB icpt-20220930_lab.xml EX-101.LAB 578295
9 EX-101.PRE icpt-20220930_pre.xml EX-101.PRE 491383
80 EXTRACTED XBRL INSTANCE DOCUMENT icpt-20220930x10q_htm.xml XML 2474110
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 221350163
SIC: 2834 Pharmaceutical Preparations